北陆药业：拟向特定对象发行股票募资不超3亿元

Core Viewpoint - Beilu Pharmaceutical (300016) plans to raise no more than 300 million yuan through a simplified procedure for specific investors, aimed at funding various projects including the production workshop and intelligent comprehensive warehouse for LZB pharmaceutical, a technical transformation project for 100 tons of Iodine Meperidine and 50 tons of Iodine Butanol raw material production lines, as well as supplementing working capital [1] Group 1 - The company intends to raise funds not exceeding 300 million yuan [1] - The raised funds will be allocated to the construction of a production workshop and intelligent warehouse [1] - The funding will also support the technical transformation of specific raw material production lines [1]